“To Compare the Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin Among Dyslipidemic Diabetic Patients at a Tertiary Centre in Bihar ”. Journal of Pharmaceutical Negative Results (February 6, 2023): 672–676. Accessed June 7, 2026. https://pnrjournal.com/index.php/home/article/view/8097.